Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease.
David John IrwinJanel FedlerChristopher S CoffeyChelsea Caspell-GarciaJu Hee KangTanya SimuniTatiana ForoudArthur W TogaCaroline M TannerKarl KieburtzLana M ChahineAlyssa ReimerSamantha HuttenDaniel WeintraubBrit MollenhauerDouglas R GalaskoAndrew SiderowfKenneth MarekJohn Q TrojanowskiLeslie M Shawnull nullPublished in: Annals of neurology (2020)
Our data suggest baseline CSF AD biomarkers may have prognostic value in early PD and that the dynamic change of these markers, although modest over a 3-year period, suggest biomarker profiles in PD may deviate from healthy aging. ANN NEUROL 2020;88:574-587.